The FDA's fast track approval process was supposed to inject some common sense and a measure of reasonableness into a system that can force device manufacturers through a labyrinthine process even when anyone could see that the product didn't need to start from square one to prove its safety. But has the fast track process been abused? Read about it in tomorrow's edition of MDD Perspectives, an op-ed e-zine that provides fresh commentary and opinions on issues that you can't find anywhere else. And best of all, it's free.

If you don't already subscribe to this complimentary e-zine, go to medicaldevicedaily.com to sign up.